TheraCell
Copenhagen, Denmark· Est.
A Danish biotech developing off-the-shelf cell therapies for tissue repair and regeneration.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $155M
AI Company Overview
A Danish biotech developing off-the-shelf cell therapies for tissue repair and regeneration.
OrthopedicsCardiovascularRegenerative Medicine
Technology Platform
A cell engineering platform that creates immune-compatible, off-the-shelf allogeneic cell therapies designed for tissue regeneration and repair.
Funding History
1Total raised:$155M
Series D$155M
Opportunities
Addressing large, underserved markets in degenerative diseases with a potentially more accessible and scalable therapeutic product.
Risk Factors
Risk of immune rejection despite engineering, and the significant technical and regulatory challenges inherent in cell therapy manufacturing and clinical development.
Competitive Landscape
Competes in the evolving allogeneic cell therapy space, where success depends on demonstrating superior efficacy and manufacturing scalability compared to autologous approaches.